Pharma Promotion / Incidents by company / Dr. Reddy's
Dr. Reddy's
4 incidents / jurisdictions: United States / sum of amounts reported: USD 5.0 m
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|---|---|---|---|
| 2018-01-19 | United States | Fine / administrative sanction | District Court Awards $5 Million in Civil Penalties and Enters Permanent Injunction to Prevent Dr. Reddy’s Laboratories Inc. from Distributing Prescription Drugs Not in Child-Resistant Packaging U.S. Department of Justice + 1 more reports | $5 Million |
| 2016-07-20 | United States | Filed / under investigation | AstraZeneca AB v. Dr. Reddy's Laboratories, Inc. District Court, D. Delaware | — |
| 2015-11-06 | United States | Other | Astrazeneca AB v. Dr. Reddy's Laboratories, Inc. District Court, D. Delaware | — |
| 2014 | United States | Warning letter / order | In December 2014 the FDA issued a Form 483 letter over concerns discovered during an inspection of its Srikakulam facility. No specific violations were mentioned in the letter. Wikipedia: Dr. Reddy's Laboratories（Issues and recalls） | — |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.